🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

BHC BHC

Company Profile ↓
$6.29
+8.82% 1Y
P/E14.98
52W High$8.34
52W Low$4.43
EPS (TTM)$0.42

Company Overview

BHC (BHC) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 16.6% CAGR over the past five years.

Reasonable Valuation

Trades at an undemanding P/E of 15.0.

Healthy Margins

Operating margin of 17.7% supports profitability.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $10.27B (+6.7% YoY); net profit $157.00M.
  • Trailing 12 Months Year-on-year growth — revenue +6.7%.
  • 5-Year Trend Long-term compounding — revenue CAGR 16.6%, profit CAGR -0.7%.

Growth & Price Performance

Compounded Sales Growth

5 Years:16.57%
1 Year:6.66%

Compounded Profit Growth

5 Years:-0.73%
1 Year:-

Stock Price Performance

1 Year:+8.82%
6 Months:+10.35%
3 Months:+11.52%
1 Month:+28.11%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 48% of range
$4.43 $8.34
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)65.46 · Neutral
Price Performance
1M+28.11%
3M+11.52%
6M+10.35%
1Y+8.82%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 16.6% over 5 years.
  • Generates positive free cash flow.

CONS

  • Earnings shrank at -0.7% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
14.98
Industry PE
-
Forward P/E est.
15.09
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
16.57%
Profit 5Y
-0.73%
Revenue (YoY)
6.66%
Earnings (YoY)
-

Profitability & Returns

ROCE
8.17%
ROE
-28.34%
ROA
0.60%
Profit Margin
1.53%
Op Margin
17.66%
Gross Margin
-
EPS (Latest Qtr)
$0.68
EPS (TTM)
$0.42

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$24.79B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
11.12%
Chg in Prom Hold
-
FII / Inst Holding
64.78%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$10.27B
EBITDA
-
Free Cash Flow
$1.00B
Operating Cash Flow
$1.40B
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026Jun 2026
Revenue -------2.11B2.23B2.22B2.16B2.00B2.13B2.14B2.12B2.02B2.15B2.21B2.22B2.01B1.66B2.14B2.21B2.03B2.10B2.11B1.92B1.97B2.05B1.94B2.17B2.24B2.15B2.40B2.51B2.26B2.53B2.68B2.52B2.85B
Operating Income 342.00M448.00M168.00M66.00M81.00M-863.00M150.00M211.00M175.00M38.00M-322.00M-2.28B-245.00M117.00M25.00M287.00M257.00M329.00M-1.08B248.00M-27.00M460.00M-5.00M-221.00M-270.00M574.00M285.00M161.00M244.00M175.00M412.00M14.00M281.00M389.00M318.00M276.00M444.00M619.00M-950.00M740.00M
Net Income --------------------152.00M-326.00M71.00M--610.00M-595.00M188.00M-69.00M-145.00M399.00M-201.00M26.00M-378.00M-64.00M10.00M-85.00M-58.00M148.00M179.00M-1.42B258.00M
Diluted EPS -0.150.14-1.12-1.08-0.88-3.49-1.471.79-0.113.691.45-7.36-2.49-1.00-0.98-0.15--0.14--0.43-0.920.20--1.71-1.660.52-0.19-0.401.10-0.550.07-1.03-0.170.03-0.23-0.160.400.48-3.820.68

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 757.18M820.43M1.18B2.43B3.48B5.77B8.21B10.45B9.67B8.72B8.38B8.60B8.03B8.43B8.12B8.76B9.62B10.27B
Operating Income 124.11M181.15M-110.08M299.96M79.70M-409.50M2.00B1.53B-566.00M102.00M-2.38B-203.00M676.00M450.00M454.00M963.00M1.55B1.81B
Net Income -176.46M-208.19M159.56M-116.00M-866.10M881.00M-292.00M-2.41B2.40B-4.15B-1.79B-560.00M-948.00M-225.00M-592.00M-46.00M157.00M
Diluted EPS 1.251.11-1.060.49-0.38-2.702.58-0.85-6.946.83-11.81-5.08-1.58-2.64-0.62-1.62-0.130.42

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --2.06B10.80B13.11B17.95B27.93B26.30B48.97B43.53B37.50B32.49B33.86B31.20B29.20B25.69B27.35B26.52B26.37B
Total Equity 1.30B1.20B1.35B4.91B3.93B3.72B5.12B5.28B5.91B3.15B5.85B2.73B1.06B535.00M-106.00M-692.00M-1.02B-1.28B-554.00M
Cash & Equivalents 433.64M317.55M114.46M394.27M164.10M916.10M600.00M323.00M597.00M542.00M720.00M721.00M3.24B605.00M582.00M564.00M947.00M1.18B1.31B
Long Term Debt --313.98M3.48B6.54B10.54B17.16B15.23B30.27B29.84B25.23B24.08B24.66B23.93B22.65B20.33B21.94B18.94B20.59B
Total Liabilities --704.92M5.88B9.18B14.23B22.74B20.90B42.94B40.27B31.55B29.68B32.73B30.59B29.24B25.43B27.43B26.84B25.99B
Current Liabilities --249.15M692.46M924.27M1.82B2.51B2.71B5.31B3.61B4.27B3.84B6.25B4.91B5.20B3.94B4.30B6.75B4.18B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 204.32M360.90M263.19M-656.60M1.04B2.31B2.26B2.09B2.29B1.50B1.50B1.11B1.43B-728.00M1.03B1.60B1.40B
Investing Cash Flow -107.83M-742.77M228.94M--2.97B-5.38B-100.00M-15.58B-125.00M2.89B-196.00M-419.00M-261.00M409.00M-303.00M-2.15B-454.00M-595.00M
Financing Cash Flow -210.31M177.05M-213.28M-3.06B4.03B-2.46B13.62B-1.96B-4.96B-1.35B1.44B-2.29B-1.51B-474.00M1.48B-868.00M-742.00M
Capital Expenditure -22.00M-7.42M-16.82M-58.52M-107.60M-115.30M-292.00M-235.00M-235.00M-171.00M-157.00M-270.00M-302.00M-269.00M-218.00M-215.00M-337.00M-397.00M
Free Cash Flow 182.33M353.47M246.37M-549.00M926.70M2.02B2.02B1.85B2.12B1.34B1.23B809.00M1.16B-946.00M817.00M1.26B1.00B
Share Buybacks 29.84M-60.13M639.24M280.70M55.60M072.00M00--------

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ------------------
Operating Margin % 16.4%22.1%-9.3%12.4%2.3%-7.1%24.4%14.6%-5.9%1.2%-28.4%-2.4%8.4%5.3%5.6%11.0%16.1%17.7%
Net Margin % -21.5%-17.6%6.6%-3.3%-15.0%10.7%-2.8%-24.9%27.6%-49.5%-20.8%-7.0%-11.2%-2.8%-6.8%-0.5%1.5%
ROE % -13.0%-4.2%4.1%-3.1%-16.9%16.7%-4.9%-76.4%41.1%-151.8%-168.2%-104.7%894.3%32.5%57.9%3.6%-28.3%
ROCE % -10.0%-1.1%2.5%0.5%-1.6%8.5%3.5%-1.4%0.3%-8.3%-0.7%2.6%1.9%2.1%4.2%7.8%8.2%

Shareholding Pattern

Insiders
11.12%
Institutions
64.78%
Public Float
72.88%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for BHC

Google News Mon, 03 Aug 2026

Bausch Health Companies Stock: 5 Straight Green Days, Up 56% - Trefis

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOeWZUMXRMeVY4SzJETmdtYWRfc0tZQVdYZ2k5Zl9BRXpreWRmVzVlUUFFd1JsUUVmbmZrc0ZNTVZ1ZldLSzhEN0phNHdGd19ZUjgyOUhpbGtSS3R6Tkw1Sk5vUFN3LXpVMXptTUFTbFhhWEdzZWUwVmJOaUlVS1o0d1lBTEhZMEpJUGJwRn…

Google News ue, 04 Aug 2026

Bausch Health Companies Inc. (BHC) Stock Analysis: Uncovering A 7.14% Upside Potential - DirectorsTalk Interviews

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNM3FsbFh4R2hOS0VwYlpzWEp0TWVXY05GQlVGbnFYbkxJVVpPTTYyNEMzaDQtVE1XOXNnLVpwdEFQdXNhTTJ4Sll6SHBGcFE2QkVVZlhlSXZYcDR5dy01azVMMmUtcjRtYXd2RzBBQlhFcm5wOEx1bnh1dTRZRzJ5OXcxX3VNcExBNzNaM2…

Google News Fri, 31 Jul 2026

BHC Stock Soars As Earnings Beat Fuels Fresh Uptrend - StocksToTrade

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxNdEVyUng1YnNxWVowMkxlcndITGRCNzZ5ZjN2bG1meGt0TGgxdHcxN18zWmIweTIwcWo2WE5NNktVSDNmTFJPMERxNUdHQ3FQckpSMm1HTUJNV3BCSkpxMEUzeDIzUnZQaE1nRUo2dDZSa09oMXlNZFRHYzYtTGI0WG1pbmYtQQ?oc=5" t…

Google News Fri, 24 Jul 2026

Bausch Health Companies Stock Price Forecast. Should You Buy BHC? - StockInvest.us

<a href="https://news.google.com/rss/articles/CBMiR0FVX3lxTE1Ua0Z0eW4yZHgyc2U3REJyUS1ZTDV2NW1ERUtscFQwek50bGR3RmZGNHU1bnRDQ2lhaTZfVUJ6a19TOUQxYXd3?oc=5" target="_blank">Bausch Health Companies Stock Price Forecast. Should You Buy BHC?</a>&n…

Google News hu, 30 Jul 2026

Bausch Health Stock (BHC) Opinions on Q2 2026 Earnings Results - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQU1gxZEoyX1loUVI3d2VJcHNmSmV5ZUI2VDVhVFE2TzUwcWNKSkVEU0NZdExfYzFBNlc5WTFhcjJNZUx2VXlTUDVJc3RGdUZzNnFmRVlfMnFUYU1qN2VGMWt4MjFUbmFiQVdJQ1piNndqMkt0Z3lxdkJDLXdKZXV4ZDRjbERNMnNTZmRKd1…

Google News Sat, 01 Aug 2026

BHC Stock Surges After Earnings Beat And Raised 2026 Outlook - timothysykes.com

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPQUxWM0UzbWxzMU5vWTR3RWwzRnhxT2NfdGV3N2paSmNaUGVrREpWUUxBckZkdUNQNV9rWWJhZmI2aG52S0t2TTBzck9KS0hnRlNkQUU0MmdyRzFfN0NrWkhFREZnSFY2dVNXNFo4ZXNVY2VqN2dXZTdpMEJYVW1ySw?oc=5" target="_…

BHC — Frequently Asked Questions

What is the current share price of BHC?

As of 2026-08-05 17:25 PDT, BHC trades at $6.29 on NASDAQ/NYSE. Its 52-week range is $4.43 to $8.34.

What is the P/E ratio of BHC?

BHC trades at a trailing price-to-earnings (P/E) ratio of 14.98.

What is the return on equity (ROE) of BHC?

BHC has a return on equity (ROE) of -28.34%. Its return on capital employed (ROCE) is 8.17%.

Is BHC a good stock to buy?

This page provides a data-driven analysis of BHC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space